MARKET

ANIP

ANIP

Ani Pharmaceutic
NASDAQ
71.44
+0.38
+0.53%
After Hours: 71.44 0 0.00% 19:30 11/13 EST
OPEN
70.54
PREV CLOSE
71.06
HIGH
72.00
LOW
70.37
VOLUME
383.86K
TURNOVER
--
52 WEEK HIGH
90.87
52 WEEK LOW
67.14
MARKET CAP
1.62B
P/E (TTM)
14.32
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ANIP last week (1102-1106)?
Weekly Report · 5d ago
ANI Pharmaceuticals Is Maintained at Buy by Guggenheim
Dow Jones · 11/06 16:22
Guggenheim Maintains Buy on ANI Pharmaceuticals, Raises Price Target to $121
Benzinga · 11/06 16:12
ANI Pharmaceuticals price target raised to $121 from $119 at Guggenheim
TipRanks · 11/06 12:07
ANI Pharmaceuticals Announces Proposed Acquisition of Egetis Therapeutics
TipRanks · 11/05 23:21
ANI Pharmaceuticals Q3 2026 Earnings Call Transcript
Benzinga · 11/05 14:46
ANI Pharmaceuticals reports Q3 adjusted EPS $2.70, consensus $2.18
TipRanks · 11/05 12:57
ANI Pharmaceuticals Reports Strong Third-Quarter Results, Expands Rare Disease Portfolio
TipRanks · 11/05 12:19
More
About ANIP
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company engaged in developing, manufacturing, and commercializing therapeutics. Its Rare Disease and Brands segment consists of two reporting units, Rare Disease and Brands. The Rare Disease unit consists of operations related to the development, manufacturing, and marketing of branded pharmaceutical products, with a focus on products used in the treatment of patients with rare disease conditions and consists of operations related to Cortrophin Gel and ILUVIEN. The Brands unit includes a portfolio of over 20 branded products that are principally sold in genericized markets. Its Generics and Other segment consists of operations related to the development, manufacturing, and marketing of generic pharmaceutical products, including those sold through traditional wholesale and retail sales channels, sales of contract manufactured products, royalties on contract manufactured products, product development services, and others.

Webull offers ANI Pharmaceuticals Inc stock information, including NASDAQ: ANIP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIP stock methods without spending real money on the virtual paper trading platform.